INCIDENCE AND MEANING OF THE " e " DETERMINANT AMONG HEPATITIS-B-ANTIGEN POSITIVE PATIENTS WITH ACUTE AND CHRONIC LIVER DISEASES

Electron microscopy of hepatitis B virus components in chronic active liver disease.

“…This third antigenic component of the HBV was discovered recently (Magnius and Espmark, 1972;Magnius et al, 1975); it is usually associated with persistent viral infection in chronic hepatitis (Nielsen et al, 1974;Eleftheriou et al, 1975;El Sheikh et al, 1975), has been localised by immunofluorescent techniques in the hepatocytic cytoplasm by one author (Trepo et al, 1976), and is usually demonstrated in the blood of chronic hepatitis B patients. In this study, all patients had chronic aggressive hepatitis (a few of them complicated by cirrhosis).…”

Age‐Specific Prevalence of Hepatitis B e Antigen (HBeAg) and Antibody to HBeAg (Anti‐HBe) among Asymptomatic Hepatitis B Surface Antigen (HBsAg) Carriers in Okinawa and Kyushu, Japan

“…Prevalences of HBeAg in asymptomatic carriers in Europe and the United States have been reported to vary from 0 to 14.3% (2,9,18,21,30). Aldershvile et al (4) have reported that the prevalence of HBeAg is different in different ethnic groups.…”

“…The presence of circulating hepatitis B e antigen (HBeAg) is closely related to the number of Dane particles (3,13,19,21,22,26,27,36), DNA polymerase activity (3,13,19,22,26,27,36), and liver damage (9,11,19,26).…”

“…In contrast, persistence of HBeAg for more than 10 weeks after the onset of illness is thought to be associated with a high risk of developing chronic hepatitis (3,21,23) this view is not shared by others, however (10,12). Ohbayashi et al (24) examined 115 Japanese asymptomatic carriers of hepatitis B surface antigen (HBsAg) and reported that serum HBeAg positivity decreased with age.…”

Early Diagnosis of Hepatitis B by Dane Particle Associated DNA Polymerase Assay

“…Since it has been reported by Nielsen et al (1974) and by Eleftheriou et al (I975) that patients with acute hepatitis who presented e antigenaemia were at a higher risk of developing chronic hepatitis than those who did not, our patients were observed to determine the evolution of their disease. We could not confirm this observation since all our patients cleared their HBs antigen between i and 2 months after the onset and their liver function was normal 6 months after the onset.…”